Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-07-01
1990-02-13
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548344, A61K 31415, C07D23364
Patent
active
049007467
ABSTRACT:
Non-peptidyl compounds characterized generally as ethereal N-terminal aminodiol derivatives of amino acids are useful as renin inhibitors for the treatment of hypertension.
REFERENCES:
Umezawa et al., J. Antibiot. (Tokyo), 23:259-262 (1970).
Gross et al., Science, 175, 656 (1971).
Boger, et al., Nature, 303, 81 (1983).
Kokubu et al., Biochim. Biophys. Res. Commun., 118, 929 (1984).
Fehrentz et al., FEBS Lett., 167, 273 (1984).
Hanson et al., Biochm. Biophys. Res. Comm., 132:155-161 (1985), 146:959-963 (1987).
Marshall, Federation Proc., 35: 2494-2501 (1976).
Burton et al., Proc. Natl. Acad. Sci. U.S.A., 77: 5476-5479 (1980).
Suketa et al., Biochemistry, 14: 3188 (1975).
Swales, Pharmac. Ther., 7: 173-201 (1979).
Kokubu et al., Nature, 217: 456-457 (1968).
Matsushita et al., J. Antibiotics, 28: 1016-1018 (1975).
Lazar et al., Biochem. Pharma., 23: 2776-2778 (1974).
Miller et al., Biochem. Pharma., 21: 2941-2944 (1972).
Haber, Clinical Science, 59: 7s-19 s (1980).
Rich et al., J. Org. Chem., 43: 3624 (1978).
Rich et al., J. Med. Chem., 23: 27 (1980).
Haber, Clin. and Exper. Hyper., A5(7&8), 1193 (1983).
Baran John S.
Hanson Gunnar J.
G. D. Searle & Co.
Keane J. Timothy
Matukaitis Paul D.
Schwartz Richard A.
LandOfFree
Ethereal N-terminal aminodiol amino acid derivatives as anti-hyp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ethereal N-terminal aminodiol amino acid derivatives as anti-hyp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ethereal N-terminal aminodiol amino acid derivatives as anti-hyp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1168389